 | • レポートコード：SR112026A33582 • 出版社/出版日：IMARC / 2026年1月 • レポート形態：英語、PDF、約100ページ • 納品方法：Eメール（納期：3日） • 産業分類：製薬 |
| Single User（1名様閲覧用） | ￥619,845 (USD3,999) | ▷ お問い合わせ |
| Five User（5名様閲覧用） | ￥774,845 (USD4,999) | ▷ お問い合わせ |
| Corporate User（閲覧人数無制限） | ￥929,845 (USD5,999) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 日本の一般用医薬品（OTC）市場規模は、2025年に110億8,400万米ドルに達した。今後、IMARC Groupは、同市場が2034年までに172億3,250万米ドルに達し、2026年から2034年にかけて年平均成長率（CAGR）5.03％で成長すると予測している。高齢化の進展、健康意識の高まり、生活習慣病の増加、製品処方の革新、政府による好意的な規制、予防医療の普及、Eコマースの普及拡大、そして天然・有機由来の医薬品代替品への移行が、市場の成長を牽引する要因となっている。 日本の一般用医薬品（OTC）市場の動向： 高齢化の進展 高齢化はOTC医薬品市場に大きな影響を与えており、セルフケアソリューションへの需要を牽引しています。これは、日本のOTC医薬品市場の成長を加速させる主要な要因の一つです。2024年9月時点で、日本の高齢者人口は65歳以上で過去最高の3,625万人に達し、総人口の29.3%を占めています。人口のかなりの割合を占める高齢層は、高血圧、関節炎、糖尿病などの慢性的な健康問題に直面することが多い。医療費の上昇が続く中、入院治療の受診機会が限られるようになるにつれ、多くの高齢者が一般的な不調を自分で管理するためにOTC医薬品を利用するようになっている。高齢者のセルフメディケーションへの移行は、医療機関への頻繁な通院を避けられるOTC製品の利便性と手頃な価格によって後押しされている。この傾向は、ドラッグストアや薬局でのOTC医薬品への広範なアクセスを支える、日本における確立された医療インフラによってさらに強められている。 健康意識の高まり 消費者の健康意識の高まりは、日本の一般用医薬品（OTC）市場シェアの成長を促進する主要な要因の一つである。予防医療を選択し、医療介入に頼る前に軽度の健康問題を自ら緩和しようとする人が増えていることが、市場の成長を後押ししている。さらに、風邪、消化器系の不調、軽度の痛みといった一般的な不調を治療するためのOTC医薬品の使用を含むセルフケアを通じて健康を維持することの利点に対する認識の高まりが、この傾向に拍車をかけている。日本人は生活習慣病の発症リスクに対する認識を高めており、その予防策を模索しています。また、メディアにおける健康関連コンテンツの増加、デジタルチャネルを通じた情報の入手可能性、および政府による健康キャンペーンも、消費者のOTC医薬品への支出意欲を後押ししています。こうした予防措置への傾向により、ビタミン剤、免疫強化剤、スキンケア製品などのOTC製品の需要が高まっており、これらが市場の拡大を牽引しています。 小売チャネルの拡大 小売チャネルの拡大は、市場の成長を牽引する重要な要因です。例えば、2025年1月の日本の小売売上高は前年同月比3.9%増となり、34ヶ月連続の成長を記録しました。このように広範な小売チャネル網を通じてOTC医薬品が入手可能になったことで、消費者は医師の診察を受けずに必要な製品を容易に入手できるようになりました。ドラッグストアは最も人気のあるチャネルの一つであり、鎮痛剤からパーソナルケア用品に至るまで、多様な消費者のニーズに応える幅広い製品を提供しています。さらに、オンライン小売の台頭により、製品の選択肢の拡大、価格比較の容易化、そして自宅への配送が可能となり、日本のOTC医薬品市場の展望をさらに明るいものにしています。さらに、流通チャネルの拡大は、様々な層への市場浸透を後押しし、競争を促進しています。これにより、製品の提供における革新と改善が促され、市場の成長をさらに刺激しています。 日本の一般用医薬品（OTC）市場のセグメンテーション： IMARC Groupは、市場の各セグメントにおける主要なトレンドの分析に加え、2026年から2034年までの国および地域レベルの予測を提供しています。本レポートでは、製品タイプ、投与経路、剤形、流通チャネルに基づいて市場を分類しています。 製品タイプ別インサイト： • 咳・風邪・インフルエンザ用製品 • 鎮痛剤 • 皮膚科用製品 • 胃腸用製品 • ビタミン・ミネラル・サプリメント（VMS） • 減量・ダイエット用製品 • 眼科用製品 • 睡眠補助剤 • その他 本レポートでは、製品タイプに基づく市場の詳細な分類と分析を提供しています。これには、咳・風邪・インフルエンザ用製品、鎮痛剤、皮膚科用製品、胃腸用製品、ビタミン・ミネラル・サプリメント（VMS）、減量・ダイエット用製品、眼科用製品、睡眠補助剤、その他が含まれます。 投与経路に関する分析： • 経口 • 非経口 • 外用 • その他 本レポートでは、投与経路に基づく市場の詳細な分類と分析も提供されています。これには、経口、非経口、外用、およびその他が含まれます。 剤形に関する分析： • 錠剤およびカプセル • 液剤 • 軟膏 • その他 本レポートでは、剤形に基づく市場の詳細な分類と分析も提供されています。これには、錠剤およびカプセル、液剤、軟膏、その他が含まれます。 流通チャネルに関する分析： • 病院薬局 • 小売薬局 • オンライン薬局 • その他 本レポートでは、流通チャネルに基づく市場の詳細な分類と分析も提供されています。これには、病院薬局、小売薬局、オンライン薬局、およびその他が含まれます。 |
The Japan over the counter (OTC) drugs market size reached USD 11,084.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 17,232.5 Million by 2034, exhibiting a growth rate (CAGR) of 5.03% during 2026-2034. Burgeoning aging population, surging health awareness, rising lifestyle diseases, innovation in product formulations, favorable government regulations, the popularity of preventive healthcare, growing e-commerce adoption, and a shift toward natural, organic drug alternatives are factors propelling the market growth.
Japan Over The Counter (OTC) Drugs Market Trends:
Growing Geriatric Population
The aging population significantly influences the OTC drug market, driving the demand for self-care solutions, which is one of the key factors accelerating the Japan over the counter (OTC) drugs market growth. As of September 2024, Japan’s elderly population reached a record high of 36.25 million individuals aged 65 or older, accounting for 29.3% of the total population. The elderly demographic, which constitutes a considerable portion of the population, often faces chronic health issues such as hypertension, arthritis, and diabetes. As healthcare costs continue to rise and the availability of in-patient treatments becomes more limited, many seniors are turning to OTC drugs for managing common ailments independently. The shift towards self-medication among older adults is encouraged by the convenience and affordability of OTC products, which allow them to avoid frequent visits to healthcare providers. This trend is further compounded by Japan’s well-established healthcare infrastructure, which supports widespread access to OTC drugs in drugstores and pharmacies.
Increased Health Awareness
Increasing health consciousness among consumers is one of the primary factors fostering the growth of the Japan over the counter (OTC) drugs market share. An increasing number of people are opting for preventative healthcare and seeking to mitigate minor health issues themselves before resorting to medical intervention, which is boosting the market growth. This is further fueled by the escalating awareness of the advantages of staying well via self-care, which encompasses the use of OTC medicines to treat common ailments like colds, digestive problems and minor aches. The Japanese are becoming increasingly cognizant of the likelihood of lifestyle diseases and searching for ways to prevent them. Consumers’ willingness to spend on OTC medications has also been driven by the increased amount of health-related content in the media, the availability of information via digital channels, as well as government health campaigns. This trend of preventative measures has led to a higher demand for several OTC products like vitamins, immunity boosters and skincare treatments which are also driving the market expansion.
Retail Channel Expansion
The expansion of retail channels is a crucial factor driving the market growth. For instance, retail sales in Japan advanced by 3.9% year-on-year in January 2025, marking the 34th consecutive month of growth. The availability of OTC drugs through such a broad network of retail channels has made it easier for consumers to access the products they need without visiting a doctor. Drugstores are among the most popular channels, offering a variety of products that cater to diverse consumer needs, from pain relievers to personal care items. Additionally, the rise of online retail has allowed for greater product selection, better price comparison, and doorstep delivery, further creating a positive Japan over the counter (OTC) drugs market outlook. Moreover, the expansion of distribution channels supports market penetration across different demographics and encourages competition, which drives innovation and improvement in product offerings, which is further stimulating the market growth.
Japan Over The Counter (OTC) Drugs Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and region level for 2026-2034. Our report has categorized the market based on product type, route of administration, dosage form, and distribution channel.
Product Type Insights:
• Cough, Cold and Flu Products
• Analgesics
• Dermatology Products
• Gastrointestinal Products
• Vitamins, Minerals and Supplements (VMS)
• Weight-loss/Dietary Products
• Ophthalmic Products
• Sleeping Aids
• Others
The report has provided a detailed breakup and analysis of the market based on the product type. This includes cough, cold and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals and supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids, and others.
Route Of Administration Insights:
• Oral
• Parenteral
• Topical
• Others
A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, parenteral, topical, and others.
Dosage Form Insights:
• Tablets and Capsules
• Liquids
• Ointments
• Others
The report has provided a detailed breakup and analysis of the market based on the dosage form. This includes tablets and capsules, liquids, ointments, and others.
Distribution Channel Insights:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, online pharmacies, and others.
レポート目次1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Over The Counter (OTC) Drugs Market – Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan Over The Counter (OTC) Drugs Market Landscape
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 Japan Over The Counter (OTC) Drugs Market – Breakup by Product Type
6.1 Cough, Cold and Flu Products
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Analgesics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Dermatology Products
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Gastrointestinal Products
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (2026-2034)
6.5 Vitamins, Minerals and Supplements (VMS)
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2020-2025)
6.5.3 Market Forecast (2026-2034)
6.6 Weight-loss/Dietary Products
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2020-2025)
6.6.3 Market Forecast (2026-2034)
6.7 Ophthalmic Products
6.7.1 Overview
6.7.2 Historical and Current Market Trends (2020-2025)
6.7.3 Market Forecast (2026-2034)
6.8 Sleeping Aids
6.8.1 Overview
6.8.2 Historical and Current Market Trends (2020-2025)
6.8.3 Market Forecast (2026-2034)
6.9 Others
6.9.1 Historical and Current Market Trends (2020-2025)
6.9.2 Market Forecast (2026-2034)
7 Japan Over The Counter (OTC) Drugs Market – Breakup by Route of Administration
7.1 Oral
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Parenteral
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Topical
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
7.4 Others
7.4.1 Historical and Current Market Trends (2020-2025)
7.4.2 Market Forecast (2026-2034)
8 Japan Over The Counter (OTC) Drugs Market – Breakup by Dosage Form
8.1 Tablets and Capsules
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Liquids
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Ointments
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Others
8.4.1 Historical and Current Market Trends (2020-2025)
8.4.2 Market Forecast (2026-2034)
9 Japan Over The Counter (OTC) Drugs Market – Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Others
9.4.1 Historical and Current Market Trends (2020-2025)
9.4.2 Market Forecast (2026-2034)
10 Japan Over The Counter (OTC) Drugs Market – Breakup by Region
10.1 Kanto Region
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Product Type
10.1.4 Market Breakup by Route of Administration
10.1.5 Market Breakup by Dosage Form
10.1.6 Market Breakup by Distribution Channel
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Product Type
10.2.4 Market Breakup by Route of Administration
10.2.5 Market Breakup by Dosage Form
10.2.6 Market Breakup by Distribution Channel
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Product Type
10.3.4 Market Breakup by Route of Administration
10.3.5 Market Breakup by Dosage Form
10.3.6 Market Breakup by Distribution Channel
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2020-2025)
10.4.3 Market Breakup by Product Type
10.4.4 Market Breakup by Route of Administration
10.4.5 Market Breakup by Dosage Form
10.4.6 Market Breakup by Distribution Channel
10.4.7 Key Players
10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
10.5.1 Overview
10.5.2 Historical and Current Market Trends (2020-2025)
10.5.3 Market Breakup by Product Type
10.5.4 Market Breakup by Route of Administration
10.5.5 Market Breakup by Dosage Form
10.5.6 Market Breakup by Distribution Channel
10.5.7 Key Players
10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
10.6.1 Overview
10.6.2 Historical and Current Market Trends (2020-2025)
10.6.3 Market Breakup by Product Type
10.6.4 Market Breakup by Route of Administration
10.6.5 Market Breakup by Dosage Form
10.6.6 Market Breakup by Distribution Channel
10.6.7 Key Players
10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
10.7.1 Overview
10.7.2 Historical and Current Market Trends (2020-2025)
10.7.3 Market Breakup by Product Type
10.7.4 Market Breakup by Route of Administration
10.7.5 Market Breakup by Dosage Form
10.7.6 Market Breakup by Distribution Channel
10.7.7 Key Players
10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
10.8.1 Overview
10.8.2 Historical and Current Market Trends (2020-2025)
10.8.3 Market Breakup by Product Type
10.8.4 Market Breakup by Route of Administration
10.8.5 Market Breakup by Dosage Form
10.8.6 Market Breakup by Distribution Channel
10.8.7 Key Players
10.8.8 Market Forecast (2026-2034)
11 Japan Over The Counter (OTC) Drugs Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 Profiles of Key Players
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.
13 Japan Over The Counter (OTC) Drugs Market – Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Appendix
病理検査サービスの日本市場（2026年～2034年） The Japan pathology lab services market size reached USD 34,925.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 77,393.3 Million by 2034, exhibiting a growth rate (CAGR) of 9.24% during 2026-2034. The market is driven by the rapid adoption of digital pathology and AI,…- 日本の廃棄物発電市場2026-2034 Japan waste-to-energy market size reached 61.2 TWh in 2025. Looking forward, IMARC Group expects the market to reach 82.6 TWh by 2034, exhibiting a growth rate (CAGR) of 3.39% during 2026-2034. The increasing consumer environmental concerns towards landfill waste that leads to climate change are pri…
- キッチン用金具の日本市場（2026年～2034年） The Japan kitchen fittings market size was valued at USD 2,120.67 Million in 2025 and is projected to reach USD 3,651.08 Million by 2034, growing at a compound annual growth rate of 6.22% from 2026-2034. The market for kitchen fittings in Japan is expanding significantly due to a number of factors, …
- 日本のウェルネスツーリズム市場2025-2033 The Japan wellness tourism market size reached USD 59.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 97.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is driven by the country's rich tradition of therapeutic practices, growi…
- 日本のスマートロック市場2025-2033 Japan smart lock market size reached USD 159.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 358.0 Million by 2033, exhibiting a growth rate (CAGR) of 9.4% during 2025-2033. The increasing adoption of smart home systems and the integration of smart locks into these ec…